Dose finding trial of yttrium 90 (90Y) ibritumomab tiuxetan with autologous stem cell transplantation (ASCT) in patients with relapsed or refractory B-cell non- Hodgkin’s lymphoma - Flinn, IW; Kahl, BS; Frey, E (Blood, 2004)